NYSE · Medical - Pharmaceuticals

TRLV (TRLV) Stock

$8.44 -5.06% NYSE: TRLV Healthcare

Valuation

MetricValue
Price$8.44
Market Cap$1.43B
P/E Ratio-21.17
P/B Ratio1.47
P/S Ratio1.29
EPS (TTM)$-0.61
52-Week High$13.28
52-Week Low$4.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-6.82%
ROA-2.92%
ROCE5.59%
Gross Margin59.65%
Operating Margin12.70%
Net Margin-6.93%
Debt/Equity0.54
Current Ratio5.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$932.0M$1.2B$1.1B$1.2B$1.2B
Operating Profit$204.0M$50.0M$-222.0M$98.0M$143.0M
Net Profit$17.0M$-253.0M$-533.0M$-161.0M$-122.0M
EPS$0.21$-0.95$-2.28$-0.79$-0.58
Op Margin22.0%4.0%-20.0%8.0%12.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.4B$3.4B$2.7B$2.9B$2.7B
Total Liabilities$1.3B$1.5B$1.3B$1.6B$1.6B
Cash$227.0M$207.0M$201.0M$239.0M$256.0M
Borrowings$463.0M$542.0M$363.0M$365.0M$137.0M

Latest News

Weekly Roundup on the Cannabis Sector & Psychedelic Sector Market Exclusive · Jul 13, 2026 Trulieve Cannabis Corp. to Hold Second Quarter 2026 Results Conference Call on August 7, 2026 PR Newswire · Jul 10, 2026 Trulieve Named to TIME's America's Best Companies 2026 List CNW Group · Jul 10, 2026 Trulieve Commemorates Georgia Medical Cannabis Launch with First Sale CNW Group · Jul 1, 2026 Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year Motley Fool · Jun 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$13.0M$23.0M$202.0M$271.0M$273.0M
Investing Cash Flow$-215.0M$-215.0M$-37.0M$-207.0M$14.0M
Financing Cash Flow$289.0M$178.0M$-176.0M$-33.0M$-270.0M
Net Cash Flow$87.0M$-14.0M$-11.0M$31.0M$16.0M
Free Cash Flow$-263.0M$-142.0M$162.0M$149.0M$229.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.22
EV / EBITDA5.40
FCF Yield14.84%
Quick Ratio3.31
Interest Coverage2.46
Return 1Y92.57%
Return 3Y112.16%
Return 5Y-74.89%

Ownership

Insiders Held1.35%
Institutions Held6.33%
Institutions Float Held6.42%
Institutional HolderSharesReport Date
Nano Cap New Millennium Growth Fund L P145,0002026-03-31
Albert D Mason Inc39,2032026-03-31
Ewa, LLC 30,2432026-06-30
Planning Project LLC252025-12-31
Ascentis Independent Advisors752026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About TRLV

TRLV is headquartered in US.

TRLV stock trades at $8.44 with a market capitalization of $1.43B. The stock is valued at a price-to-earnings (P/E) ratio of -21.17, price-to-book of 1.47, price-to-sales of 1.29. Over the past 52 weeks the stock has ranged between $4.00 and $13.28, and currently trades 36.4% below its 52-week high.

On profitability, TRLV generates a return on equity (ROE) of -6.82%, return on capital employed of 5.59%, an operating margin of 12.70%, a net profit margin of -6.93%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides